GenScript Biotech Corporation（Stock Code: 1548.HK）is a global biotechnology group. GenScript’s businesses encompass four major categories based on its leading gene synthesis technology, including operation as a Life Science CRO, enzyme and synthetic biology products, biologics development and manufacturing, as well as cell therapy.
Founded in 2002 and listed on the Hong Kong Stock Exchange in 2015, GenScript has an established global presence across Greater China, North America, the EU, and Asia Pacific. Today, over 300,000 customers from over 160 countries and regions around the world have used GenScript’s premier, convenient, and reliable products and services.
GenScript currently has more than 2900 employees globally, 34% of whom hold master’s and/or Ph.D. degrees. In addition, GenScript has a number of leading commercial technologies, including more than 100 patents and over 270 patent applications. As of June 2019, GenScript's products and services have been cited by 40,300 scientific papers worldwide.
GenScript is committed to striving towards its vision of being the most reliable biotech company in the world to make humans and nature healthier through biotechnology.
For more information, please visit https://www.genscript.com/.
|Registered office in the
|4th Floor, Harbour Place
103 South Church Street, George Town
P.O. Box 10240, Grand Cayman KY1-1002
(information contained in these websites does not form part of
|Company secretary||Ms. Wong Wai Ling (黃慧玲)
(a member of the Hong Kong Institute of
|Authorized representatives||Dr. Zhang Fangliang (章方良)
Mr. Meng Jiange (孟建革)
|Principal share registrar
and transfer office
Harneys Services (Cayman) Limited
4th Floor, Harbour Place
103 South Church Street
P.O. Box 10240
Grand Cayman KY1-1002
|Hong Kong Share Registrar||Computershare Hong Kong Investor Services Limited
17th Floor, Hopewell Centre
183 Queen's Road East